Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-21-009339
Filing Date
2021-02-10
Accepted
2021-02-10 17:28:40
Documents
1
Period of Report
2020-11-16

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 5850
  Complete submission text file 0001209191-21-009339.txt   7315
Mailing Address C/O SYROS PHARMACEUTICALS, INC. 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address
Young Richard A (Reporting) CIK: 0001490283 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37813 | Film No.: 21615232

Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Issuer) CIK: 0001556263 (see all company filings)

EIN.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations